Residency Listing

University of North Carolina Medical Center
Pharmacy Administration
101 Manning Drive
Chapel Hill, NC 27514
Code: 36110
NMS Code: 595460
Postgraduate Year Two (PGY2)
Oncology Pharmacy
Accreditation Status: Accredited
Residency Program Director: Jill S Bates, Pharm.D., MS, BCOP
(984) 974-8241
Director of Pharmacy: Scott W. Savage, Pharm.D., MS
(984) 974-6642
Fax: (984) 974-7163
Residency Information:
Duration/Type: 12 mo. residency
Number of Positions: 4
Application Deadline: 2019-01-01
Starting Date: 2019-07-01
Estimated Stipend: 50000
Interview Required: Yes
Residency Special Features:   The University of North Carolina Medical Center, in conjunction with the University of North Carolina Eshelman School of Pharmacy, offers a 12 month post graduate year 2 specialty residency in oncology pharmacy. The focus of the residency program is adult hematology and oncology in both the acute and ambulatory practice settings. Opportunities are also available in bone marrow transplantation, gynecologic management, and precision medicine.
Fringe Benefits:   20 PTO days per year; professional development salary allocation
Special Requirements for Acceptance:   Acceptable professional education record, letters of reference, eligibility for North Carolina licensure, and completion of an ASHP-accredited pharmacy practice (PGY1) residency. This residency participates in PhORCAS. Our website details additional requirements, including questions to answer and a standardized reference form. Please refer to our website for details:
Training Site Type: Hospital
Owner Affiliate: Government (State)
Model Type(s): Teaching, Tertiary
Tax Status: Nonprofit
Professional Staff: 249
Non-Professional Staff: 274
Number of Medical Centers: 4
Total Beds: 933
Average Daily Census: 802
Site Special Features:   The department is committed to a practice model that directly involves pharmacists in patient care. Pharmaceutical care services are largely decentralized and are supported by a centralized distribution system using state-of-the-art technology.